Post-liver transplant obesity and diabetes

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 6, Issue 4, 2003, Pages 457-460

  Correia, M Isabel T D ^a,b   Ordones Rego, Luciana ^a   Soares Lima, Agnaldo ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Mario Penna Hospital   (Brazil)

Author keywords

Diabetes; Immunosuppressive drugs; Liver transplantation; Morbidity; Mortality; Obesity

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

CARBOHYDRATE INTOLERANCE; COUNSELING; DIABETES MELLITUS; EATING HABIT; HIGH RISK PATIENT; HUMAN; LIVER TRANSPLANTATION; METABOLIC ACTIVATION; MORBIDITY; MORTALITY; OBESITY; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RECIPIENT; REVIEW; RISK FACTOR; SURVIVAL TIME;

EID: 13644250481     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mco.0000078994.96795.d8     Document Type: Review

References (27)

1. Bismuth H, Farges O, Cataing D, et al. Evaluation of results of liver transplantation: experiences based on a series of 1052 transplantations. Presse Med 1995; 24:1106-1114.
2. Wood RP, Ozaki CF, Katz SM, et al. Liver transplantation: the last ten years. Surg Clin North Am 1994; 74:1133-1154.
3. Asfar S, Metrakos P, Freyer J, et al. An analysis of late deaths after liver transplantation. Transplantation 1996; 61:1377-1381.
4. Pruthi J, Medkiff KA, Esrason KT, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001; 7:811-815. This paper assesses the causes of death in long-term survivors of orthotopic liver transplantation. The authors reviewed the causes of death among 299 adult liver transplant recipients who survived more than 3 years after transplantation at two centers and were able to show that cardiovascular complications accounted for more than half the late deaths.
5. Sheiner PA, Magliocca JF, Bodian CA, et al. Long-term medical complications in patients surviving ≥5 years after liver transplant. Transplantation 2000; 69:781-789.
6. Everhart JE, Lombardero M, Lake JR, et al. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg 1998; 4:285-296.
7. Appignani BA, Bhadelia RA, Blacklow SC, et al. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. Am J Radiol 1996; 166:683-688.
8. Canzanello VT, Schwartz L, Taler SJ, et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997; 3:1-9.
9. Munoz SJ, Deems RO, Moritz MJ, et al. Hyperlipidemia and obesity after orthotopic liver transplantation. Transplant Proc 1991; 21:1480-1483.
10. Palmer M, Schaffner F, Thung SN. Excessive weight gain after liver transplantation. Transplantation 1991; 51:797-800.
11. Wahlstrom HE, Cooper J, Gores G, et al. Survival after liver transplantation in diabetes. Transplant Proc 1991; 23:1565-1566.
12. Navasa M, Bustamante J, Marroni C, et al. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996; 25:64-71.
13. Canzanello VJ, Schwartz L, Tater SJ, et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK 506). Liver Transpl Surg 1997; 3:1-9.
14. Le Cornu KA, McKiernan FJ, Kapadia SA, Neuberger JM. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation 2000; 69:1364-1369.
15. Ratcliffe J, Longworth L, Young T, et al. Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study. Liver Transpl 2002; 8:263-270.
16. Reuben A. Long-term management of the liver transplant patient: diabetes, hyperlipidemia and obesity. Liver Transpl 2001; 7:313-321. An elegant review of the risk factors associated with the development of cardiovascular complications in long-term liver transplantation survivals.
17. Munoz SJ. Long-term management of the liver transplant recipient. Clin Liver Dis 2000; 4:691-710.
18. Pedrides AS, DeFronzo RA. Glucose metabolism in cirrhosis: a review with some perspectives for the future. Diabetes Metab Rev 1989; 5:691-709.
19. Stegall MD, Everson G, Shorter G, et al. Metabolic complications after liver transplantation: diabetes, hypercholesterolemia and obesity. Transplantation 1995; 60:1057-1060.
20. Shields PL, Tang H, Neuberger JM, et al. Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 1999; 68:530-535.
21. Marroni CA, Hoppe L, Diehl JL, et al. Diabetes mellitus and liver transplantation in adults. Transplant Proc 1999; 31:3046.
22. Blanco JJ, Herrereo JI, Quiroga J, et al. Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival and adverse events. Liver Transpl 2001; 7:226-233. A cohort study that assessed the prevalence of diabetes before liver transplantation and correlated it to postoperative development of diabetes.
23. Munoz SJ. Long-term management of the liver transplant recipient. Med Clin North Am 1996; 80:1103-1119.
24. Navasa M, Bustamante M, Marroni C, et al. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996; 25:64-71.
25. Steinmuller TH, Stockmann M, Bechstein WO, et al. Liver transplantation and diabetes mellitus. Exp Clin Endocrinol Diabetes 2000; 108:401-405.
26. Rabkin JM, Corless CL, Rosen HR, et al. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg 2002; 183:595-599. The authors investigate the incidence of metabolic complications in two cohorts of post-liver transplant patients. In one group the patients received tacrolimus and the other group were given cyclosporine. They observed that those patients receiving tacrolimus had a decreased incidence of cardiovascular complications.
27. Otto G, Bleyl J, Neuhaus P, et al. Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporine in primary liver transplantation. Transpl Int 1994; 7 (Suppl 1):S7-S10.